Skip to content

Multiple omics study of Esophageal cancer

Multiple omics study of Esophageal squamous cell carcinoma

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026389
Enrollment
Unknown
Registered
2019-10-07
Start date
2019-11-01
Completion date
Unknown
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

stage 1:none
stage 2:none
stage 3:none
stage 4:none

Sponsors

The Fifth Affiliated Hospital, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients with esophageal squamous cell carcinoma who can receive radical surgery and are pathologically diagnosed as squamous cell carcinoma; (2) Patients with tumor tissues, adjacent tissues, peripheral blood, stool and esophageal mucus can be obtained according to the sample requirements; (3) Provide informed consent prior to the commencement of any trial-related steps.

Exclusion criteria

Exclusion criteria: (1) Discontinue treatment if medical procedures are not followed; (2) Patients who cannot provide complete clinical information (image data, pathological data and treatment plan); (3) According to the judgment of the researcher, the patient also had other serious diseases that might affect the follow-up and short-term survival; (4) Any other medical condition or social/psychological problem that the researcher has determined is inappropriate for the patient to participate in this study.

Design outcomes

Primary

MeasureTime frame
genomics;microbiome;metabonomics;

Countries

China

Contacts

Public ContactQingdong Cao

The Fifth Affiliated Hospital, Sun Yat-Sen University

15013813866@163.com+86 13680356988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026